摘要
An expert in cardiocerebral vascular diseases, Zhao Buchang （赵步长）, the 65-yearold chairman of Buchang Group （步长集团）, set up Buchang in 1993 after one of the medicines he helped develop -- the Buchang Naoxintong capsule, which is used to treat diseases of the heart and encephalon blood vessels -- became a financial success.
